Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2006

Chen X, Zhang J, Lee J, Lin PS, Ford JM, Zheng N, et al. A kinase-independent function of c-Abl in promoting proteolytic destruction of damaged DNA binding proteins. Mol Cell. 2006;22(4):489-99.

Guo C, Inghirami G, Ibrahim S, Sen F. Epistaxis and severe weakness in a patient with multiple myeloma. Therapy-related acute myeloid leukemia, pure erythroid leukemia. Arch Pathol Lab Med. 2006;130(7):1075-6.

Ruan J, Hyjek E, Kermani P, Christos PJ, Hooper AT, Coleman M, et al. Magnitude of stromal hemangiogenesis correlates with histologic subtype of non-Hodgkin's lymphoma. Clin Cancer Res. 2006;12(19):5622-31.

Magro CM, A Crowson N, Mihm MC. Unusual variants of malignant melanoma. Mod Pathol. 2006;19 Suppl 2:S41-70.

A Crowson N, Magro C, Mihm MC. Unusual histologic and clinical variants of melanoma: implications for therapy. Curr Treat Options Oncol. 2006;7(3):169-80.

Rossi S, Ou W, Tang D, Bhattacharya N, Tos AP, Fletcher JA, et al. Gastrointestinal stromal tumours overexpress fatty acid synthase. J Pathol. 2006;209(3):369-75.

Piva R, Chiarle R, Manazza AD, Taulli R, Simmons W, Ambrogio C, et al. Ablation of oncogenic ALK is a viable therapeutic approach for anaplastic large-cell lymphomas. Blood. 2006;107(2):689-97.

Magro CM, Abbas AE, Seilstad K, Pope-Harman AL, Nadasdy T, Ross P. C3d and the septal microvasculature as a predictor of chronic lung allograft dysfunction. Hum Immunol. 2006;67(4-5):274-83.

Lee JW, Chen Q, Knowles DM, Cesarman E, Y Wang L. beta-Glucuronidase is an optimal normalization control gene for molecular monitoring of chronic myelogenous leukemia. J Mol Diagn. 2006;8(3):385-9.

Khandelwal A, Seilstad KH, Magro CM. Subclinical chronic lymphocytic leukaemia associated with a 13q deletion presenting initially in the skin: apropos of a case. J Cutan Pathol. 2006;33(3):256-9.